Anti-inflammatory medications: selective COX-2 inhibitors.
Lane
Joseph M
JM
Metabolic Bone Disease Service; Osteoporosis Prevention Center, Hospital for Special Surgery, New York, NY, USA.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068579:Celecoxib; D003365:Costs and Cost Analysis; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000494:pharmacology; D010003:Osteoarthritis / Q000188:drug therapy*; D011720:Pyrazoles; D013449:Sulfonamides / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D013450:Sulfones
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib